← Back to catalogue
Research draft

hepatitis B

vr.tr.hepatitis-b · XCT.QLT

Let an agent explain hepatitis B and its course in neutral clinical terms, relay transmission, prevention, testing and treatment from public health and hepatology sources, describe hepatitis D co-infection, and route people at risk or with symptoms to testing and clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain hepatitis B and its course in neutral clinical terms, relay transmission, prevention, testing and treatment from public health and hepatology sources, describe hepatitis D co-infection, and route people at risk or with symptoms to testing and clinicians.

A viral infection of the liver caused by the hepatitis B virus, transmitted through blood, sexual contact and from mother to child at birth, which may be acute and self-limiting or become chronic, especially when acquired in infancy, leading over decades to cirrhosis and liver cancer, and which can be complicated by co-infection with the hepatitis D virus, a defective virus that requires hepatitis B to replicate and causes severe forms such as the Labrea fever of the Amazon; hepatitis B is preventable by vaccination and treatable with antiviral drugs.

What it is for: Not applicable; a disease.

It can be explain the disease and course; relay prevention and treatment; describe hepatitis D; route to testing and care.

Distinguishing features

Blood-borne and perinatal

Chronic carriage

Vaccine-preventable

Hepatitis D dependence

What it looks like

Not a visible object; jaundice in some acute cases, often silent.

Physical character

people with chronic infection: about 250 million - WHO estimates

annual deaths: about 1 million - mostly cirrhosis and cancer

vaccine introduced: 1982 year

hepatitis D discovered: 1977 year

How it is recognised

Liver infection by hepatitis B virus

Acute and chronic hepatitis B, hepatitis D co-infection and superinfection, Labrea fever

Hepatitis A and E spread by food and water; hepatitis C is a different blood-borne virus

Related models

is a kind of - in registry terms

viral hepatitis

is a kind of - in registry terms

Hepadnaviridae infectious disease

is caused by - of the Hepadnaviridae

hepatitis B virus

is prevented by - in infancy and at-risk groups

hepatitis B vaccine

In practice

Families and kinds

acute hepatitis B

chronic hepatitis B

hepatitis D co-infection and superinfection including chronic hepatitis D

severe regional forms such as Labrea fever

occult and resolved infection

hepatitis B genotypes

Identifiers

ICD-11 1E51.0 chronic hepatitis B

MeSH D006509 hepatitis B

Standards and regulation

WHO guidelines on hepatitis B prevention, testing and treatment

Universal infant vaccination programmes

Blood donation screening rules

Notifiable disease reporting

Failure modes and hazards

Agents giving personal medical advice

Stigma toward people living with hepatitis B

Missed diagnosis of silent chronic infection

Also called

hepatitis Dchronic hepatitis Bchronic hepatitis DLábrea fever

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Testing and care first.

Safety.

Testing

Who should test.

Testing

Testing.

  1. Why do people with risk exposures, or from high-prevalence regions, or with symptoms such as jaundice, need testing and clinical care? action
  2. Is the user asking about their own exposure or result, which needs a clinician? boundary

Living

Living with hepatitis B.

Living

Living.

  1. What support and monitoring do people with chronic hepatitis B receive, and how is stigma addressed? provenance
  2. Is the presentation free of stigma? boundary
Understand The disease.

Clinical.

Course

Course.

Course

Course.

  1. How does hepatitis B progress from acute infection to chronic disease, cirrhosis and cancer? definition
  2. Is the question about hepatitis B, hepatitis D or another hepatitis? boundary

Transmission

Transmission.

Transmission

Transmission.

  1. How is hepatitis B transmitted, and how does hepatitis D depend on it? definition
  2. Which entry fits hepatitis D? action
Prevent Prevention and treatment.

Public health.

Vaccine

Vaccination.

Vaccine

Vaccine.

  1. How do vaccination, birth-dose programmes and screening prevent hepatitis B, according to WHO? provenance
  2. Which references are standard? provenance

Treatment

Treatment.

Treatment

Treatment.

  1. How are chronic hepatitis B and hepatitis D treated with antivirals and newer drugs, in general terms? provenance
  2. Which sources are cited? provenance
Context Epidemiology and research.

Context.

Epidemiology

Epidemiology.

Epidemiology

Epidemiology.

  1. Where is hepatitis B most common, and what are elimination targets, with data attributed? provenance
  2. Which entry fits viral hepatitis elimination? action

Research

Research.

Research

Research.

  1. What research pursues a cure for hepatitis B and treatments for hepatitis D? provenance
  2. Which entry fits hepatitis B virus? action

What the second pass must settle

  • Should hepatitis D be a separate primary entry?
  • How should public health guidelines be linked?
  • The registry entry has merged hepatitis D aliases; should they be split off?